Kangstem Biotech Decides on 50 Billion KRW Rights Offering to Shareholders
[Asia Economy Reporter Yoo Byung-don] Kangstem Biotech announced on the 2nd that it has decided to conduct a rights offering followed by a general public offering of forfeited shares to raise approximately 50 billion KRW for operating funds and other purposes.
Hot Picks Today
!["Stock Set to Double: This Company Smiles Every Time a Data Center Is Built [Click e-Stock]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026050416112750184_1777878687.jpg)
"Stock Set to Double: This Company Smiles Every...
- "Is Yours Just Gathering Dust at Home? Millennials & Gen Z Rediscover Digicams O...
- "Continuous Groundwater Pumping Causes Mexico City to Sink 24cm Annually... 'Gia...
- Constitutional Preamble Amendment Hung on Gwangju City Hall Wall... "Inheriting ...
- “She Shouted, ‘The Rope Isn’t Tied!’... Chinese Woman Falls from 168m Cliff ...
New shares totaling 12,376,237 common shares will be issued at 4,040 KRW per share.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
